MOONWALK
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jan 2032: the §8 declaration of use).
Record
- Serial number
- 98977271
- Registration number
- 8120869
- Mark type
- Stylized text
- Filed
- 02 Oct 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 27 Jan 2026
- Next maintenance filing
- §8 declaration of use, due by 27 Jan 2032 (grace period to 27 Jul 2032)
- Attorney of record
- Michael J. Allan
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases
Owner
- Moonwalk Biosciences, South San Francisco, CA
- Moonwalk Biosciences, South San Francisco, CA
- Moonwalk Biosciences, South San Francisco, CA
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jul 2025 — USE AMENDMENT FILED
- 02 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 11 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 02 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED